Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags:
Controversial practices of some companies, Changes in the marketing strategies and practices of companies like Pfizer.
Grouped Articles
Glaxo Epilepsy Drug Is Linked to Defects Found in Newborns - WSJ.com
Wall Street Journal 10/02/2006
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11/29/2006
AstraZeneca Vows to Work With FDA - WSJ.com
Wall Street Journal 11/28/2006
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11/21/2006
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05/10/2007
BusinessWeek 05/21/2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05/22/2007
The efforts of pharmaceutical companies to promote their drugs in medical journal articles and research.
Grouped Articles
Novartis Hit by Scandal Over Japanese Drug Studies
Wall Street Journal 08/11/2013
How Quiet Moves by a Publisher Sway Billions in Drug Spending - WSJ.com
Wall Street Journal 10/06/2006
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Maker Said to Pay Ghostwriters for Journal Articles
New York Times 12/12/2008
FDA Finalizes Medical Journal Promotion Rules
Wall Street Journal 01/14/2009
Grouped Articles
Wall Street Journal 01/19/2006
Weak Sales Prompt Pfizer to Cancel Diabetes Drug
New York Times 10/19/2007
Pfizer Unit, UCB Form a Venture
Wall Street Journal 10/21/2008
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12/11/2008
Pfizer Plans to Lay Off Up to 2,400 in Sales
Wall Street Journal 01/17/2009
Pfizer Deal to Buy Wyeth Leaves Doubts
Wall Street Journal 01/27/2009
American and European drug companies are slimming down marketing and sales as the old marketing practices are not working, and new strategies are taking their place.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Wall Street Journal 01/16/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Wall Street Journal 10/21/2008
The advertising efforts and budgets of pharmaceutical companies and the risks to consumers of improper advertising.
Grouped Articles
Drug Makers to Police Consumer Campaigns
New York Times 08/03/2005
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Putting Drug Ads Back In The Bottle
BusinessWeek 08/13/2007
Making a Name for Drugs Without Using Their Names
Wall Street Journal 08/29/2008
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12/11/2008
Drug Firms' Spending on Consumer Ads Fell 8% in '08, a Rare Marketing Pullback
Wall Street Journal 04/16/2009
Old ways are disappearing, and the pharmaceutical industry will look very different ten years from now from what it is today.
Grouped Articles
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/2007
New York Times 06/25/2009
New Conflict Rules at Medical Journals
Wall Street Journal 10/14/2009
Using a Pfizer Grant, Courses Aim to Avoid Bias
New York Times 01/11/2010
Drug Firms Feel Pinch From Europe
Wall Street Journal 07/29/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1